Antiemesis, version 2.2017 featured updates to the NCCN guidelines

Michael J. Berger, David S. Ettinger, Jonathan Aston, Sally Barbour, Jason Bergsbaken, Philip Jay Bierman, Debra Brandt, Dawn E. Dolan, Georgiana Ellis, Eun Jeong Kim, Steve Kirkegaard, Dwight D. Kloth, Ruth Lagman, Dean Lim, Charles Loprinzi, Cynthia X. Ma, Victoria Maurer, Laura Boehnke Michaud, Lisle M. Nabell, Kim NoonanEric Roeland, Hope S. Rugo, Lee S. Schwartzberg, Bridget Scullion, John Timoney, Barbara Todaro, Susan G. Urba, Dorothy A. Shead, Miranda Hughes

Research output: Contribution to journalReview article

47 Citations (Scopus)

Abstract

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Antiemesis address all aspects of management for chemotherapy-induced nausea and vomiting. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines for Antiemesis, specifically those regarding carboplatin, granisetron, and olanzapine.

Original languageEnglish (US)
Pages (from-to)883-893
Number of pages11
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume15
Issue number7
DOIs
StatePublished - Jul 1 2017

Fingerprint

Guidelines
olanzapine
Granisetron
Carboplatin
Practice Guidelines
Nausea
Vomiting
Drug Therapy

ASJC Scopus subject areas

  • Oncology

Cite this

Antiemesis, version 2.2017 featured updates to the NCCN guidelines. / Berger, Michael J.; Ettinger, David S.; Aston, Jonathan; Barbour, Sally; Bergsbaken, Jason; Bierman, Philip Jay; Brandt, Debra; Dolan, Dawn E.; Ellis, Georgiana; Kim, Eun Jeong; Kirkegaard, Steve; Kloth, Dwight D.; Lagman, Ruth; Lim, Dean; Loprinzi, Charles; Ma, Cynthia X.; Maurer, Victoria; Michaud, Laura Boehnke; Nabell, Lisle M.; Noonan, Kim; Roeland, Eric; Rugo, Hope S.; Schwartzberg, Lee S.; Scullion, Bridget; Timoney, John; Todaro, Barbara; Urba, Susan G.; Shead, Dorothy A.; Hughes, Miranda.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 15, No. 7, 01.07.2017, p. 883-893.

Research output: Contribution to journalReview article

Berger, MJ, Ettinger, DS, Aston, J, Barbour, S, Bergsbaken, J, Bierman, PJ, Brandt, D, Dolan, DE, Ellis, G, Kim, EJ, Kirkegaard, S, Kloth, DD, Lagman, R, Lim, D, Loprinzi, C, Ma, CX, Maurer, V, Michaud, LB, Nabell, LM, Noonan, K, Roeland, E, Rugo, HS, Schwartzberg, LS, Scullion, B, Timoney, J, Todaro, B, Urba, SG, Shead, DA & Hughes, M 2017, 'Antiemesis, version 2.2017 featured updates to the NCCN guidelines', JNCCN Journal of the National Comprehensive Cancer Network, vol. 15, no. 7, pp. 883-893. https://doi.org/10.6004/jnccn.2017.0117
Berger, Michael J. ; Ettinger, David S. ; Aston, Jonathan ; Barbour, Sally ; Bergsbaken, Jason ; Bierman, Philip Jay ; Brandt, Debra ; Dolan, Dawn E. ; Ellis, Georgiana ; Kim, Eun Jeong ; Kirkegaard, Steve ; Kloth, Dwight D. ; Lagman, Ruth ; Lim, Dean ; Loprinzi, Charles ; Ma, Cynthia X. ; Maurer, Victoria ; Michaud, Laura Boehnke ; Nabell, Lisle M. ; Noonan, Kim ; Roeland, Eric ; Rugo, Hope S. ; Schwartzberg, Lee S. ; Scullion, Bridget ; Timoney, John ; Todaro, Barbara ; Urba, Susan G. ; Shead, Dorothy A. ; Hughes, Miranda. / Antiemesis, version 2.2017 featured updates to the NCCN guidelines. In: JNCCN Journal of the National Comprehensive Cancer Network. 2017 ; Vol. 15, No. 7. pp. 883-893.
@article{a53ddc1f724740fca3fcf347f57427a1,
title = "Antiemesis, version 2.2017 featured updates to the NCCN guidelines",
abstract = "The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Antiemesis address all aspects of management for chemotherapy-induced nausea and vomiting. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines for Antiemesis, specifically those regarding carboplatin, granisetron, and olanzapine.",
author = "Berger, {Michael J.} and Ettinger, {David S.} and Jonathan Aston and Sally Barbour and Jason Bergsbaken and Bierman, {Philip Jay} and Debra Brandt and Dolan, {Dawn E.} and Georgiana Ellis and Kim, {Eun Jeong} and Steve Kirkegaard and Kloth, {Dwight D.} and Ruth Lagman and Dean Lim and Charles Loprinzi and Ma, {Cynthia X.} and Victoria Maurer and Michaud, {Laura Boehnke} and Nabell, {Lisle M.} and Kim Noonan and Eric Roeland and Rugo, {Hope S.} and Schwartzberg, {Lee S.} and Bridget Scullion and John Timoney and Barbara Todaro and Urba, {Susan G.} and Shead, {Dorothy A.} and Miranda Hughes",
year = "2017",
month = "7",
day = "1",
doi = "10.6004/jnccn.2017.0117",
language = "English (US)",
volume = "15",
pages = "883--893",
journal = "JNCCN Journal of the National Comprehensive Cancer Network",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "7",

}

TY - JOUR

T1 - Antiemesis, version 2.2017 featured updates to the NCCN guidelines

AU - Berger, Michael J.

AU - Ettinger, David S.

AU - Aston, Jonathan

AU - Barbour, Sally

AU - Bergsbaken, Jason

AU - Bierman, Philip Jay

AU - Brandt, Debra

AU - Dolan, Dawn E.

AU - Ellis, Georgiana

AU - Kim, Eun Jeong

AU - Kirkegaard, Steve

AU - Kloth, Dwight D.

AU - Lagman, Ruth

AU - Lim, Dean

AU - Loprinzi, Charles

AU - Ma, Cynthia X.

AU - Maurer, Victoria

AU - Michaud, Laura Boehnke

AU - Nabell, Lisle M.

AU - Noonan, Kim

AU - Roeland, Eric

AU - Rugo, Hope S.

AU - Schwartzberg, Lee S.

AU - Scullion, Bridget

AU - Timoney, John

AU - Todaro, Barbara

AU - Urba, Susan G.

AU - Shead, Dorothy A.

AU - Hughes, Miranda

PY - 2017/7/1

Y1 - 2017/7/1

N2 - The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Antiemesis address all aspects of management for chemotherapy-induced nausea and vomiting. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines for Antiemesis, specifically those regarding carboplatin, granisetron, and olanzapine.

AB - The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Antiemesis address all aspects of management for chemotherapy-induced nausea and vomiting. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines for Antiemesis, specifically those regarding carboplatin, granisetron, and olanzapine.

UR - http://www.scopus.com/inward/record.url?scp=85022329776&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85022329776&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2017.0117

DO - 10.6004/jnccn.2017.0117

M3 - Review article

C2 - 28687576

AN - SCOPUS:85022329776

VL - 15

SP - 883

EP - 893

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

SN - 1540-1405

IS - 7

ER -